Login / Signup

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach.

Susann-Cathrin OlthofAndrea ForschnerPeter MartusClaus GarbeKonstantin NikolaouChristian Peter la FougèreBrigitte GückelWerner VachChristina Pfannenberg
Published in: European journal of nuclear medicine and molecular imaging (2020)
The use of PET/CT in advanced melanoma patients, primarily not considered for surgery, resulted in frequent changes of management associated with a relevant expected clinical benefit especially in patients classified by PET/CT as tumour-free or eligible for radical surgery.
Keyphrases